BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26256467)

  • 1. Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN).
    Wojczynski MK; Parnell LD; Pollin TI; Lai CQ; Feitosa MF; O'Connell JR; Frazier-Wood AC; Gibson Q; Aslibekyan S; Ryan KA; Province MA; Tiwari HK; Ordovas JM; Shuldiner AR; Arnett DK; Borecki IB
    Metabolism; 2015 Oct; 64(10):1359-71. PubMed ID: 26256467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics of Postprandial Lipidomics in the Genetics of Lipid-Lowering Drugs and Diet Network Study.
    Irvin MR; Montasser ME; Kind T; Fan S; Barupal DK; Patki A; Tanner RM; Armstrong ND; Ryan KA; Claas SA; O'Connell JR; Tiwari HK; Arnett DK
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge.
    Lai CQ; Wojczynski MK; Parnell LD; Hidalgo BA; Irvin MR; Aslibekyan S; Province MA; Absher DM; Arnett DK; Ordovás JM
    J Lipid Res; 2016 Dec; 57(12):2200-2207. PubMed ID: 27777315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Association Study of the Postprandial Triglyceride Response Yields Common Genetic Variation in LIPC (Hepatic Lipase).
    Ibi D; Noordam R; van Klinken JB; Li-Gao R; de Mutsert R; Trompet S; Christen T; Blauw LL; van Heemst D; Mook-Kanamori DO; Rosendaal FR; Jukema JW; Dollé MET; Rensen PCN; van Dijk KW
    Circ Genom Precis Med; 2020 Aug; 13(4):e002693. PubMed ID: 32603185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate.
    Aslibekyan S; Goodarzi MO; Frazier-Wood AC; Yan X; Irvin MR; Kim E; Tiwari HK; Guo X; Straka RJ; Taylor KD; Tsai MY; Hopkins PN; Korenman SG; Borecki IB; Chen YD; Ordovas JM; Rotter JI; Arnett DK
    PLoS One; 2012; 7(10):e48663. PubMed ID: 23119086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide study of lipid response to fenofibrate in Caucasians: a combined analysis of the GOLDN and ACCORD studies.
    Irvin MR; Rotroff DM; Aslibekyan S; Zhi D; Hidalgo B; Motsinger-Reif A; Marvel S; Srinivasasainagendra V; Claas SA; Buse JB; Straka RJ; Ordovas JM; Borecki IB; Guo X; Chen IY; Rotter JI; Wagner MJ; Arnett DK
    Pharmacogenet Genomics; 2016 Jul; 26(7):324-33. PubMed ID: 27002377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study.
    Irvin MR; Aslibekyan S; Do A; Zhi D; Hidalgo B; Claas SA; Srinivasasainagendra V; Horvath S; Tiwari HK; Absher DM; Arnett DK
    Clin Epigenetics; 2018; 10():56. PubMed ID: 29713391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
    Wojczynski MK; Glasser SP; Oberman A; Kabagambe EK; Hopkins PN; Tsai MY; Straka RJ; Ordovas JM; Arnett DK
    Lipids Health Dis; 2011 Oct; 10():181. PubMed ID: 22008512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
    Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
    Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment.
    Smith JA; Arnett DK; Kelly RJ; Ordovas JM; Sun YV; Hopkins PN; Hixson JE; Straka RJ; Peacock JM; Kardia SL
    Eur J Hum Genet; 2008 May; 16(5):603-13. PubMed ID: 18212815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study.
    Irvin MR; Kabagambe EK; Tiwari HK; Parnell LD; Straka RJ; Tsai M; Ordovas JM; Arnett DK
    Circ Cardiovasc Genet; 2010 Oct; 3(5):462-7. PubMed ID: 20729559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association studies identified novel loci for non-high-density lipoprotein cholesterol and its postprandial lipemic response.
    An P; Straka RJ; Pollin TI; Feitosa MF; Wojczynski MK; Daw EW; O'Connell JR; Gibson Q; Ryan KA; Hopkins PN; Tsai MY; Lai CQ; Province MA; Ordovas JM; Shuldiner AR; Arnett DK; Borecki IB
    Hum Genet; 2014 Jul; 133(7):919-30. PubMed ID: 24604477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics of post-prandial lipidomic phenotypes in the Genetics of Lipid lowering Drugs and Diet Network (GOLDN) study.
    Irvin MR; Zhi D; Aslibekyan S; Claas SA; Absher DM; Ordovas JM; Tiwari HK; Watkins S; Arnett DK
    PLoS One; 2014; 9(6):e99509. PubMed ID: 24905834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of 16 NMR-lipoprotein fractions in humans, the GOLDN study.
    Kraja AT; Borecki IB; Tsai MY; Ordovas JM; Hopkins PN; Lai CQ; Frazier-Wood AC; Straka RJ; Hixson JE; Province MA; Arnett DK
    Lipids; 2013 Feb; 48(2):155-65. PubMed ID: 23192668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A replication study of GWAS-derived lipid genes in Asian Indians: the chromosomal region 11q23.3 harbors loci contributing to triglycerides.
    Braun TR; Been LF; Singhal A; Worsham J; Ralhan S; Wander GS; Chambers JC; Kooner JS; Aston CE; Sanghera DK
    PLoS One; 2012; 7(5):e37056. PubMed ID: 22623978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.
    Delgado-Lista J; Perez-Jimenez F; Ruano J; Perez-Martinez P; Fuentes F; Criado-Garcia J; Parnell LD; Garcia-Rios A; Ordovas JM; Lopez-Miranda J
    J Lipid Res; 2010 Jan; 51(1):63-73. PubMed ID: 19592705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort.
    Geng X; Irvin MR; Hidalgo B; Aslibekyan S; Srinivasasainagendra V; An P; Frazier-Wood AC; Tiwari HK; Dave T; Ryan K; Ordovas JM; Straka RJ; Feitosa MF; Hopkins PN; Borecki I; Province MA; Mitchell BD; Arnett DK; Zhi D
    J Lipid Res; 2018 Apr; 59(4):722-729. PubMed ID: 29463568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between LRP-1 variants and chylomicron uptake after a high fat meal.
    Frazier-Wood AC; Kabagambe EK; Wojczynski MK; Borecki IB; Tiwari HK; Smith CE; Ordovas JM; Arnett DK
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1154-8. PubMed ID: 23484911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study.
    Kathiresan S; Manning AK; Demissie S; D'Agostino RB; Surti A; Guiducci C; Gianniny L; Burtt NP; Melander O; Orho-Melander M; Arnett DK; Peloso GM; Ordovas JM; Cupples LA
    BMC Med Genet; 2007 Sep; 8 Suppl 1(Suppl 1):S17. PubMed ID: 17903299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.